<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">If regulatory bottlenecks prevent solutions being brought to the public in time to reduce the impact of an epidemic, then we need to consider alternatives that deliver solutions at an earlier stage of an epidemic, in the geographical jurisdictions where the outbreak is occurring. Governments can leverage harmonized regulatory standards, mutual recognition, and regulatory reliance mechanisms to enhance existing regulatory pathways and accelerate and coordinate approvals globally
 <xref rid="p0140" ref-type="p">x</xref>. This would be particularly beneficial in countries that traditionally suffer submission and approval lags for novel drugs and vaccines.
</p>
